“Mesenchymal stem cell” or MSCs refer to cells isolated from stroma, the connective tissue that surrounds other tissues and organs. These cells can be harvested from bone marrow, placentas, umbilical cords, and fat. MSCs are pluripotent – or capable of giving rise to other different cell types – and offer regenerative effects for tissue while moderating the immune system.
MSCs offer two primary properties: tissue regeneration and immunomodulatory (immune moderating) effects. StemSmart is made from cultivated MSCs that are treated according to a patented process, offering more efficacious cells with the potential to treat a variety of immune and inflammatory disorders.
It is important to note that not all MSCs are the same. Their characteristics depend on where in the body they come from and how they are isolated and grown. Isopogen has a patented process to treat MSCs, resulting in more clinically efficacious cells.
While clinical trials of MSC products made using StemSmart™ have focused on the treatment of Crohn’s Disease, the potential of MSCs to treat other auto-immune diseases is widely published, suggesting significant potential across a range of auto-immune conditions like Rheumatoid Arthritis.